Self-efficacy and healthy lifestyle behaviors as mediators between COVID-19 care knowledge and health status.

Self-efficacy and healthy lifestyle behaviors as mediators between COVID-19 care knowledge and health status.

Publication date: Dec 28, 2024

The COVID-19 epidemic has affected the psychological well-being and daily life of college students, leading to a decrease in their quality of life. Health status can be influenced by a variety of factors. This study aims to assess the current health status of university students and explore the relationships among COVID-19 care knowledge, self-efficacy, healthy lifestyle behaviors, and health status and how these factors are influenced. Among the 1694 participants, 49. 4% were male, 50. 6% were female, and 82. 2% were freshmen. The results revealed that health status across all dimensions decreased to some extent. COVID-19 care knowledge affected both physical and mental component summaries. The results suggest that improving COVID-19 care knowledge, strengthening self-efficacy, and promoting the development of healthy lifestyle behaviors can positively impact their health status. Here, we explore the health status of college students with COVID-19 infection and the factors and mechanisms that influence it to guide health interventions to better meet the challenges posed by future outbreaks.

Open Access PDF

Concepts Keywords
Covid Adolescent
Daily Adult
Decrease COVID-19
Female COVID-19 care knowledge
Freshmen Female
Health Behavior
Health Status
Health status
Healthy Lifestyle
Healthy lifestyle behaviors
Humans
Male
Quality of Life
SARS-CoV-2
Self Efficacy
Self-efficacy
Students
Surveys and Questionnaires
Universities
Young Adult

Semantics

Type Source Name
disease MESH lifestyle
disease MESH COVID-19
disease MESH health status
disease MESH psychological well-being
disease IDO quality
disease MESH infection
drug DRUGBANK Tropicamide
disease MESH emergency
disease MESH anxiety
disease MESH depression
disease MESH sequelae
disease MESH dyspnea
disease IDO production
disease MESH sore throat
disease MESH joint pain
drug DRUGBANK Coenzyme M
disease IDO nucleic acid
drug DRUGBANK Methionine
disease IDO role
disease IDO process
disease MESH overweight
disease MESH Obesity
disease MESH Chronic diseases
disease MESH infectious diseases
disease IDO susceptibility
disease MESH sedentary lifestyle
drug DRUGBANK Ribostamycin
drug DRUGBANK Guanosine
disease MESH weight gain
disease IDO country
disease MESH oral health
disease IDO intervention
disease MESH heart failure
disease MESH Parkinson’s disease
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)